Juergen Scheuenpflug

Darmstadt, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.

Journal: Pharmacogenomics

Published: March 21, 2024

Real-world genomic landscape of colon and rectal cancer.

Real-world genomic landscape of colon and rectal cancer.

Journal: FEBS open bio

Published: March 19, 2024

Clinical Impact of Sub-Clonal RAS/BRAF Alterations in Liquid Biopsies From Patients With Advanced or Metastatic CRC.

Clinical Impact of Sub-Clonal RAS/BRAF Alterations in Liquid Biopsies From Patients With Advanced or Metastatic CRC.

Journal: Clinical colorectal cancer

Published: December 18, 2023

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.

Journal: NPJ precision oncology

Published: February 25, 2023

Comparison of Two Illumina Whole Transcriptome RNA Sequencing Library Preparation Methods Using Human Cancer FFPE Specimens.

Comparison of Two Illumina Whole Transcriptome RNA Sequencing Library Preparation Methods Using Human Cancer FFPE Specimens.

Journal: Technology in cancer research & treatment

Published: February 09, 2022

Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding.

Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding.

Journal: Oncoimmunology

Published: September 06, 2021

Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping.

Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping.

Journal: JCO precision oncology

Published: March 30, 2021

Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.

Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.

Journal: BMC cancer

Published: January 25, 2021

Fit-for-purpose quantitative liquid biopsy based droplet digital PCR assay development for detection of programmed cell death ligand-1 (PD-L1) RNA expression in PAXgene blood samples.

Fit-for-purpose quantitative liquid biopsy based droplet digital PCR assay development for detection of programmed cell death ligand-1 (PD-L1) RNA expression in PAXgene blood samples.

Journal: PloS one

Published: January 15, 2021

Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.

Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 06, 2019

The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P-Glycoprotein Substrate Digoxin in Healthy Volunteers.

The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P-Glycoprotein Substrate Digoxin in Healthy Volunteers.

Journal: Clinical pharmacology in drug development

Published: April 26, 2018

Precision Medicine in Oncology and Immuno-Oncology: Where We Stand and Where We're Headed.

Precision Medicine in Oncology and Immuno-Oncology: Where We Stand and Where We're Headed.

Journal: Biomedicine hub

Published: August 28, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026